“Right to Try” (Again): A history of the experimental therapy movement BY LUCAS RICHERT APRIL 16, 2018 CULTURE, HISTORY, POLITICS, RESEARCH In recent weeks and months, momentum has increased on Capitol Hill to craft “right to try” laws that would profoundly change the medical landscape. The national legislation will allow terminally ill patients more access to experimental therapies […]Read more "The Right to Try"
Bill Booth kindly invited me on to his podcast to discuss health and medicine. Bill is one of the founders of Radical Americas, an academic network for scholars and activists with interests in radicalism in the Western Hemisphere. Here I spoke with the #radical @WilliamABooth about health, medicine, science and death! Have a listen if […]Read more "Radical Health"
The ADHS is pleased to announce that the editorship of its journal, *The Social History of Alcohol and Drugs*, will be taken over by Prof. Nancy D. Campbell (Rensselaer Polytechnic Institute), Prof. David Herzberg (Buffalo) and Dr. Lucas Richert (Strathclyde). The society would also like to express its gratitude for the work that outgoing editor, […] […]Read more "New Editors at Social History of Alcohol and Drugs"
Any of this stock market record due to Big Pharma boost from Jeff Sessions new memo against people's right to legal cannabis? https://t.co/HQotfSGzAl — Martha Densmore (@Acubody) January 4, 2018 Big Pharma wanted to sell more opioids. Then this happened..#opioidcrisis #opioid @conradhackett pic.twitter.com/rpHxGDeytW Alternatives, such as cannabis *cannot* overdose and are *way less* addictive — […]Read more "Big Pharma Round-Up V (#Cannabis edition)"
I wrote about Lambert Publishers last month. And they’ve come back at me again. They want to publish an article of mine. Lambert is, of course, a ‘predatory publisher,’ and the company is all about cashing in on other’s work. Here’s what they wrote me earlier this month. Again, I went to school for a […]Read more "To publish…"
Here is a snapshot of the past week in Big Pharma news. This is coming at you a little early because of the Christmas slowdown. Happy holidays. To kick off: The drug industry spent big! Threats to high drug prices prompted biggest lobbying/PR/advertising/influence-buying surge by trade group PhRMA in nearly a decade. We got their […]Read more "Big Pharma Round-Up II"
A round up of the recent Big Pharma and FDA stories. Antibiotics in Farm Animals Drop: https://www.theatlantic.com/health/archive/2017/12/antibiotics-farm-animal/547904/ Teva Pharmaceuticals is being reshaped: Rebooting the FDA: https://www.politico.com/agenda/story/2017/12/13/fda-approval-alternatives-000593 On AstraZeneca: https://www.digitallook.com/news/broker-recommendations/astrazenecas-drug-pipeline-call-reinforces-barclays-top-pick-in-sector–3031953.html Top 5 Stories of 2017: https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/5-top-pharmaceutical-stories-2017/ FDA clears the Apple watch: .@US_FDA clears first medical device accessory for Apple Watch https://t.co/6paPq5EOti @Reuters pic.twitter.com/2BGoSyPth8 — Jay […]Read more "Big Pharma Round-Up"